• FirefoxInstall the new Firefox »
  •  Dow Down0.06% Nasdaq Up0.42%

    Revance Therapeutics, Inc. (RVNC)

    -NasdaqGM
    16.46 Up 0.05(0.30%) Feb 26, 4:00PM EST
    Add to Portfolio
    Insider RosterGet Insider Roster for:
    Insider Holders*
    Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
    BERTOLINO ARTHUR PETER
    Officer
    Acquisition (Non Open Market)
    Jan 28, 2015
    45,453
    Jan 28, 2015
    BROWNE L DANIEL
    Officer
    Acquisition (Non Open Market)
    Jan 28, 2015
    288,161
    Jan 28, 2015
    BYRNES ROBERT F
    Director
    Acquisition (Non Open Market)
    Sep 17, 2014
    2,666
    Sep 17, 2014
    EASTMAN RONALD W
    Director
    Acquisition (Non Open Market)
    Feb 11, 2014
    4,134,962

    Feb 11, 2014
    ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP
    Beneficial Owner (10% or more)
    Option Exercise
    Feb 11, 2014
    4,134,962

    Feb 11, 2014
    GARDNER PHYLLIS
    Director
    Acquisition (Non Open Market)
    Feb 11, 2014
    457,085

    Feb 11, 2014
    GLASHEEN JAMES WALTER
    Director
    Acquisition (Non Open Market)
    Feb 11, 2014
    726,014

    Feb 11, 2014
    NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.
    Beneficial Owner (10% or more)
    Option Exercise
    Feb 11, 2014
    3,096,650

    Feb 11, 2014
    RUEGG CURTIS
    Officer
    Automatic Sale
    Feb 17, 2015
    19,337
    Feb 17, 2015
    SILVERNAIL LAUREN P
    Officer
    Acquisition (Non Open Market)
    Jan 28, 2015
    23,270
    Jan 28, 2015
    TUNNICLIFFE JONATHAN
    Director
    Acquisition (Non Open Market)
    Feb 11, 2014
    3,096,650

    Feb 11, 2014
    WAUGH JACOB
    Officer
    Acquisition (Non Open Market)
    Jan 28, 2015
    31,544
    Jan 28, 2015
    WOOTEN RONALD J
    Director
    Acquisition (Non Open Market)
    Feb 11, 2014
    3,096,650

    Feb 11, 2014

    View Transactions for Insiders & Institutional Holders

     
    * Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.